Target & Activity
| Target | Activity | Value |
|---|---|---|
| IKK2 (Cell-free assay) | 0.3 μM | |
| IKK1 (Cell-free assay) | 4 μM |
Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| A549 | IC50 | 5.6 μM | Cytotoxicity against human A549 cells measured after 72 hrs by MTT assay | [PMID: 27886548] |
| A549 | IC50 | 8.6 μM | Cytotoxicity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay | [PMID: 29655083] |
| Jurkat | CC50 | 100 μM | Cytotoxicity against Jurkat cells by Alamar blue assay | [PMID: 17540562] |
| L02 | IC50 | 15.3 μM | Cytotoxicity against human HL7702 cells assessed as reduction in cell viability after 72 hrs by MTT assay | [PMID: 29655083] |
| Lewis lung carcinoma cell line | IC50 | 4.8 μM | Cytotoxicity against mouse LLC cells measured after 72 hrs by MTT assay | [PMID: 27886548] |
| NCI-H1650 | IC50 | 19.9 μM | Cytotoxicity against human NCI-H1650 cells measured after 72 hrs by MTT assay | [PMID: 27886548] |
| NCI-H1650 | IC50 | 9.3 μM | Cytotoxicity against human NCI-H1650 cells assessed as reduction in cell viability after 72 hrs by MTT assay | [PMID: 29655083] |
| NCI-H1975 | IC50 | 8 μM | Cytotoxicity against human NCI-H1975 cells assessed as reduction in cell viability after 72 hrs by MTT assay | [PMID: 29655083] |
| NCI-H460 | IC50 | 2.8 μM | Cytotoxicity against human H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay | [PMID: 29655083] |
| PBMC | IC50 | 1000 nM | Antiinflammatory activity in human PBMC assessed as inhibition of LPS-induced TNFalpha release treated for 5 mins before LPS challenge measured after 6 hrs by ELISA | [PMID: 21087862] |
10 records · Scroll to view more